

InterviewSolution
Saved Bookmarks
1. |
Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?(a) Bapineuzumab(b) Alzhemed(c) Flurizan(d) DoxilI had been asked this question in an interview.I would like to ask this question from Chemical Basis of Life topic in portion Chemical Basis of Life of Cell Biology |
Answer» The correct answer is (C) Flurizan |
|